Rarity Bioscience superRCA technology assays

Wednesday, 12 March, 2025 | Supplied by: Beckman Coulter Australia


As part of a co-exclusive distribution agreement, Beckman Coulter Life Sciences will market and distribute Rarity Bioscience’s superRCA technology assays. The assays are claimed to accelerate the detection of mutations by using flow cytometry with logarithmically higher sensitivity compared to the current gold standard digital PCR (dPCR) method.

While traditional flow cytometry research analyses phenotypes, the platform combines a molecular assay based on rolling circle amplification and padlock probes with a flow cytometry readout for high sensitivity and specific multiplex detection of sequence variants, including single point DNA mutations. The assay offers high throughput, resulting in fast turnaround without the need for additional hardware, lowering the barriers to molecular research assays.

Online: www.beckman.com.au
Phone: 1800 060 878
Related Products

PBL Assay Science Interferon ELISA Kits

PBL Assay Science's Interferon ELISA Kits are designed to be easily adopted in a regulated...

EpigenTek EpiNext CUT&LUNCH Assay Kit

Enabling highly specific enrichment of target protein–DNA complexes, the assay kit...

Mercodia C-peptide ELISA

Mercodia's C-peptide ELISA is a highly specific tool that is calibrated against the...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd